NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

NCT05131763 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Glioblastoma
Medulloblastoma
Colon Cancer

Interventions

BIOLOGICAL: NKG2D-based CAR T-cells

Sponsor

Fudan University

Collaborators

[object Object]